by Richard Daverman, PhD
June 15, 2012 -- Wuhan Humanwell Healthcare will pay 776 million RMB ($122 million) to purchase an 80% stake in Beijing Baron Medical Equipment, the largest distributor of Roche’s in-vitro diagnostic products in China. Baron Medical also began distributing Diagnostic Technology’s blood coagulation products in Beijing two years ago. To pay for the acquisition, Humanwell will raise 1 billion RMB ($157 million) in a private placement. More details....
Stock Symbol: (SHA: 600079)
